Novartis Financial Results – Q3 2019

Novartis announced the company’s financial results for the third quarter of 2019.

Oct 22, 2019

Media Release

English (PDF 0.1 MB) | Deutsch (PDF 0.2 MB) | Français (PDF 0.3 MB) 

Interim financial report (PDF 0.8 MB) 

Investor Presentation

Download the presentation (PDF 1.3 MB)

Executive Committee of Novartis (ECN) Biographies

ECN Biographies

Novartis Corporate Fact Sheet

The corporate fact sheet provides a comprehensive overview of Novartis overall as well as our divisions (Innovative Medicines, Sandoz), our research (NIBR) and development (Global Drug Development) organizations, and outlines our commitment to associates as well as Corporate Responsibility.

Read the Corporate Fact Sheet

Related Links